• CHIC2, 4q12 Deletion (FIP1L1 and PDGFRA Fusion), FISH, Blood
  • Rapid Plasma Reagin (RPR), CSF
  • MGMT (O-6-methylguanine-DNA methyltransferase) Methylation Detection
  • Glucose Tolerance Test
  • HER2/neu (ERBB2), IHC, Semi Quantitative, Automated
  • Methohexital, Urine
  • Autoimmune thyroiditis
  • Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • Cardio inCode-Score for Cardiovascular Risk Assessment
  • Secondary hypertension
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Circulating Tumor Cells (CTC), Prostate Cancer
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Circulating Tumor Cells (CTC), Prostate Cancer
Medical Test

Turnaround Time
Access to Circulating Tumor Cells (CTC), Prostate Cancer is restricted.